The markets continued falling during the midday with the Dow plummeting 148 points to 17,561. Nasdaq tumbled 41 points to 4,734.
On the upside
Top Image Systems (Nasdaq: TISA) reported higher first quarter revenue.
The Patent Trial and Appeal Board sided with Coherus BioSciences (Nasdaq: CHRS) by agreeing to review AbbVie's (NYSE: ABBV) patent on the arthritis treatment Humira.
Second quarter earnings slipped for Cemtrex (Nasdaq: CETX) but revenue climbed.
On the downside
Red Robin Gourmet Burgers (Nasdaq: RRGB) reported lower first quarter earnings as revenue fell short of expectations prompting the casual dining chain to lower its full year forecast.
Aegerion Pharmaceuticals (Nasdaq: AEGR) widened first quarter losses more than expected as revenue tumbled prompting the company to cut its full year revenue outlook.
Oclaro (Nasdaq: OCLR) will present at several upcoming investor conferences.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 fell 9 points to 2,056. Bitcoin edged up a fraction to $454.
Markets continue falling
May 17, 2016 at 15:13 PM EDT